Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-009733

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James F Tessmer
Officer — VP, Finance & Accounting
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2018M1,340—A21,435D
Common StockF1Feb 28, 2018M2,668—A24,103D
Common StockF1Feb 28, 2018M2,075—A26,178D
Common StockF1Feb 28, 2018M1,270—A27,448D
Common StockFeb 28, 2018F1,805$8.53D25,643D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Feb 28, 2018M1,340D——Common Stock1,3400D
Restricted Stock UnitsF1,F4—Feb 28, 2018M2,668D——Common Stock2,6682,668D
Restricted Stock UnitsF1,F5—Feb 28, 2018M2,075D——Common Stock2,0754,150D
Restricted Stock UnitsF1,F6—Feb 28, 2018M1,270D——Common Stock1,2703,810D

Explanation of responses